• Newton Biocapital I invests in J-Pharma Co., Ltd. in Japan focusing on drug development targeting L-type Amino Acid Transporter 1 (LAT1) for cancer and autoimmune diseases

    Thursday August 27th 2020

  • Vlaanderen investeert ruim kwart miljoen euro in Belgische Google van de genetica

    Wednesday August 26th 2020

  • Persomed appoints Kristof Vercruysse as CEO to drive personalized cancer vaccine venture’s successful implementation

    Monday August 24th 2020

  • Galapagos announces that Gilead received a complete response letter for filgotinib for the treatment of moderately to severely active rheumatoid arthritis

    Wednesday August 19th 2020

  • Mithra announces commercial launch of Myring™ in the Netherlands

    Wednesday August 19th 2020

  • BioLizard awarded €300,000 VLAIO research grant to establish causal link between the microbiome and disease

    Monday August 17th 2020

  • Becoming a nerve cell: timing is of the essence

    Monday August 17th 2020

  • Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease

    Thursday August 13th 2020

  • Your news here?

  • Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

    Thursday August 13th 2020

  • BISC Global opens in Switzerland

    Wednesday August 12th 2020

  • Precigen ActoBio announces positive topline results from Phase 1b study of AG019 ActoBiotics

    Tuesday August 11th 2020

Strategic Partners